Increased cerebrospinal-fluid pressure during treatment of diabetic ketosis.
D000208:Acute Disease; D000328:Adult; D001344:Autopsy; D001786:Blood Glucose / Q000378:metabolism; D001929:Brain Edema / Q000139:chemically induced / Q000473:pathology; D002245:Carbon Dioxide / Q000378:metabolism; D002555:Cerebrospinal Fluid; D003243:Consciousness; D016883:Diabetic Ketoacidosis / Q000188:drug therapy*; D005260:Female; D005632:Fructose / Q000134:cerebrospinal fluid; D005947:Glucose / Q000134:cerebrospinal fluid / Q000378:metabolism; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin / Q000009:adverse effects / Q000627:therapeutic use; D007427:Intracranial Pressure; D008297:Male; D010313:Partial Pressure; D011188:Potassium / Q000097:blood; D011312:Pressure; D012964:Sodium / Q000097:blood; D013997:Time Factors; D014474:Unconsciousness
D001786:Blood Glucose; D007328:Insulin; D002245:Carbon Dioxide; D005632:Fructose; D012964:Sodium; D005947:Glucose; D011188:Potassium